Ezetimibe and Simvastatin
VYTORIN
HMG-CoA Reductase Inhibitor
NADAC/unit
$0.3177
No Shortage
Tier 1: 171.4%
PA Req: 0.9%
4 Manufacturers
16 ANDAs
Ezetimibe and Simvastatin lowers LDL cholesterol and triglycerides to reduce cardiovascular risk.
vs. brand VYTORIN: Generic saves up to 97% per unit
Market Intelligence
2025-06-18 Class III Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
ALKEM LABORATORIES LTDAUROBINDO PHARMA USA INCDR REDDYS LABORATORIES SAGLENMARK PHARMACEUTICALS LTDORGANON LLC A SUB OF ORGANON AND CO
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.